K

Yuanbio Venture Capital logo

Yuanbio Venture Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

2

Common Fundraising Type

Series A

AusperBio logo
AusperBio

Biotechnology • Oligonucleotide Therapies

AusperBio is a biotechnology company developing targeted oligonucleotide therapies for chronic hepatitis B and other chronic diseases.

Series B
$73M
12/26/2024
Article
Allink Biotherapeutics logo
Allink Biotherapeutics

Biotechnology • Clinical-stage

Allink Biotherapeutics is a clinical-stage biotechnology company focused on developing bispecific antibodies and antibody-drug conjugates (ADCs) for global clinical applications.

Series A
$42M
11/28/2024
Article